INTRODUCTION
Neisseria gonorrhoeae is a gram-negative diplococcus that is found only in humans and causes the sexually transmitted disease gonorrhea. Given that it is a strictly human pathogen and can colonize both male and female genital mucosal surfaces and other sites, it has developed mechanisms to overcome antimicrobial systems of the host's innate defense. One major mechanism that N. gonorrhoeae uses to resist antimicrobial agents is the expression of multidrug efflux pumps that recognize and actively export a variety of structurally unrelated toxic compounds from the bacterial cell, including antibacterial peptides, long-chain fatty acids, and several clinically important antibiotics (Lee and Shafer, 1999; Rouquette-Loughlin et al., 2003; Shafer et al., 1998 Shafer et al., , 2001 Unemo and Shafer, 2014) .
The best characterized efflux system in N. gonorrhoeae is the MtrC-MtrD-MtrE multidrug efflux system (Delahay et al., 1997; Lucas et al., 1995; Hagman et al., , 1997 Veal and Shafer, 2003; Warner et al., 2008) . This system is similar to other efflux pumps of the resistance-nodulation-cell division (RND) superfamily (Tseng et al., 1999) possessed by many Gram-negative bacteria. MtrD (Bolla et al., 2014; Hagman et al., , 1997 is the inner membrane transporter component of the tripartite RND pump. The complex is formed by interactions between MtrD, the periplasmic membrane fusion protein MtrC (Hagman et al., , 1997 Veal et al., 2002; Janganan et al., 2013) , and the outer membrane channel MtrE (Delahay et al., 1997; Lei et al., 2014b; Janganan et al., 2011 Janganan et al., , 2013 . This powerful efflux complex mediates the export of several structurally diverse hydrophobic antimicrobial agents, such as antibiotics, nonionic detergents, antibacterial peptides, bile salts, and gonadal steroidal hormones (Delahay et al., 1997; Hagman et al., , 1997 Shafer et al., 1998) . In addition, the Mtr efflux system includes another inner membrane protein MtrF (Veal and Shafer, 2003; Folster and Shafer, 2005) , which belongs to the AbgT family of transporters (Prakash et al., 2003) . It has been proposed that MtrF cooperates with the MtrC-MtrD-MtrE complex to export certain antimicrobials by a yet-unknown mechanism (Veal and Shafer, 2003) .
To date, approximately 13,000 putative transporters of the AbgT family have been identified. AbgT-type proteins are commonly found in Gram-negative bacteria such as Salmonella enterica, Gram-positive bacteria such as Staphylococcus aureus, as well as yeasts such as Saccharomyces arboricola. Surprisingly, among proteins in this diverse family, only Escherichia coli AbgT (Hussein et al., 1998; Carter et al., 2007) and N. gonorrhoeae MtrF (Folster and Shafer, 2005; Veal and Shafer, 2003) have been partially characterized. Thus far, there is no structural information available for this family of membrane proteins, obscuring the details of their function and mechanism.
The products of the E. coli abg genes have been shown to catalyze the uptake and cleavage of the folate catabolite p-aminobenzoyl-glutamate (Carter et al., 2007) . Particularly, E. coli AbgT has been demonstrated to import the catabolite p-aminobenzoyl-glutamate for de novo folic acid synthesis (Carter et al., 2007) . As E. coli AbgT and N. gonorrhoeae MtrF belong to the same family of transporters, there is a chance that the MtrF protein may also act as an importer to uptake p-aminobenzoylglutamate and related small molecules for the synthesis of the essential folate vitamin. However, since MtrF is needed for the high-level resistance of gonococci to hydrophobic antimicrobials, including erythromycin and TX-100 (Folster and Shafer, 2005) , it seems more likely that it participates in drug efflux. To understand the transport functions of members of the AbgT family, we here present the crystal structure of the N. gonorrhoeae MtrF transporter. Importantly, we show that N. gonorrhoeae MtrF is capable of exporting the folate metabolite p-aminoben- zoic acid (PABA) from cells. A combination of the three-dimensional structure and genetic analysis allows us to identify key MtrF residues that are important for the function of this membrane protein.
Finally, we demonstrate that MtrF behaves as an antibiotic efflux pump, which is responsible for removing sulfonamides from the cell and mediating bacterial resistance to this class of antimetabolites.
RESULTS AND DISCUSSION
Overall Structure of N. gonorrhoeae MtrF The N. gonorrhoeae MtrF transporter is composed of 522 amino acids, sharing 38% identity with E. coli AbgT ( Figure S1 ). The crystal structure of this membrane protein was determined to a resolution of 3.95 Å (Table S1 ). Two molecules of MtrF, which assemble as a dimer, are found in the asymmetric unit ( Figure S2 ; Figure 1 ). Superimposition of these two MtrF molecules gives an RMSD of 0.5 Å over 506 Ca atoms, indicating that their conformations are nearly identical to each other. The dimeric form of MtrF in the crystal lattice is in good agreement with the oligomerization state of this membrane protein in detergent solution in which it also assembles as a dimer ( Figure S3 ).
The fold of MtrF is unique and composed of a number of unusual structural elements. Each subunit of MtrF comprises nine a-helical transmembrane segments and two helical hairpins: TM1 (a [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [462] [463] [464] [465] [466] [467] [468] [469] [470] [471] ) and TM9 ). It should be noted that five of these TMs (TM1, TM2, TM3, TM7, and TM8) are broken into segments within the membrane. In addition, HP1 and HP2 are formed by relatively short helices, which are only long enough to span half of the membrane ( Figures 1A and 1B) . Interestingly, the intramembrane loops of several of these TMs and HPs are right next to each other, allowing the transporter to form an internal cavity within the membrane ( Figures 1C and 1D ). Noticeably, our structure indicates that the N-and C-terminal ends of MtrF are located at different sides of the inner membrane ( Figures  1A and 1B) . As there was no signaling peptide added when expressing the MtrF protein, the N-terminal end of this protein should be located at the cytoplasm. Thus, the C-terminal end of MtrF should be positioned within the periplasmic space. This is in good agreement with the predicted E. coli AbgT topology that the C-terminal end of this protein is located at the periplasm (Daley et al., 2005) .
Each protomer of MtrF contains a relatively small periplasmic domain. This domain is made up of two long loops formed between TMs 1 and 2, and TMs 5 and 6, respectively. Below the inner leaflet of the membrane, a small cytoplasmic domain links TMs 4 and 5 together. This domain comprises a relatively long random loop and helix (a1) ( Figure 1A) .
Viewed in parallel to the membrane, the MtrF dimer is bowl shaped with a concave aqueous basin facing the intracellular solution ( Figure 1B ). The dimer is about 75 Å tall, 80 Å wide, and 50 Å thick, with the transmembrane portion of the transporter lying approximately in the middle. The rim of the basin is as large as 45 Å . The bowl-shaped structure is 25 Å in depth and deeply penetrates into the inner leaflet of the cytoplasmic membrane ( Figure 1C ). This basin probably allows aqueous solution to reach the midpoint of the membrane bilayer. Interestingly, a similar bowl-shaped structure has also been found in the glutamate transporter (Yernool et al., 2004) . However, the bowl shape, which deeply penetrates into the membrane, is formed within the trimer of this transporter (Yernool et al., 2004) .
The structure of the MtrF dimer can be roughly divided into the inner and outer cores (Figure 2 ). The inner core contains TMs 1, 2, 5, 6, and 7, creating a frame-like structure to house the outer core of the protein (Figure 2A) . A portion of this inner core is responsible for forming a dimerization domain of the transporter. Viewed along the membrane normal, TMs 1b, 2a, 2b, 6, 7a, and 7b, as well as their counter parts from the next subunit, contribute to this distinct dimerization domain.
Noticeably, the outer core of the MtrF protomer, comprising TMs 3, 4, 8, and 9 as well as HPs 1 and 2, folds into a cylindrical structural feature (Figure 2A ). It is most likely that this outer core cylinder forms a substrate-binding site and transport pathway. Based on the crystal structure, the outer core cylinder contributes to form a tunnel spanning approximately from the middle of the inner membrane up to the periplasmic space (Figures 2B and S4) . This tunnel is surrounded with HPs 1 and 2, as well as TMs 3 and 8. Interestingly, this tunnel is connected to the cytoplasmic space through an opening located at the basin of the bowl-shaped structure. The loop regions of HP1, HP2, TM3, and TM8 form this opening. Several conserved residues, including D193, S417, W420, P438, R446, D449, and P457, are found to line the wall of the channel ( Figure 2B ). These residues may play an important role for the function.
MtrF Is Capable of Exporting p-Aminobenzoic Acid from the Cell As E. coli AbgT has been shown to enable uptake of the folate catabolite p-aminobenzoyl-glutamate (Carter et al., 2007) 1.0 mM MgSO 4 , 20.0 mM NH 4 Cl, and 22.2 mM glucose) supplemented with p-aminobenzoyl-glutamate. Based on several studies on folic acid transporters (Eudes et al., 2010; Klaus et al., 2005; Salcedo-Sora et al., 2011) , we made an E. coli knockout strain BL21(DE3)DabgTDpabA that lacks the abgT gene (Hussein et al., 1998; Carter et al., 2007) to impede uptake of the catabolite p-aminobenzoyl-glutamate and pabA gene (Kaplan and Nichols, 1983) to impair intracellular synthesis of the metabolite PABA. We then transformed these double-knockout cells with pET15bUmtrF, expressing N. gonorrhoeae mtrF, or the empty vector pET15b. Surprisingly, the double-knockout E. coli BL21(DE3)DabgTDpabA cells, transformed with either pET15bUmtrF or pET15b, could not grow in this liquid medium supplemented with p-aminobenzoyl-glutamate up to 1 mM. However, these cells were capable of growing in liquid minimal medium when supplemented with 30 nM PABA. Within the E. coli abg operon, there are two additional genes, abgA and abgB, located upstream of abgT. The products of these two genes are the AbgA and AbgB aminoacyl aminohydrolases, which cleave the catabolite p-aminobenzoyl-glutamate imported by the AbgT transporter to form PABA for folic acid synthesis (Carter et al., 2007) . In contrast, the mtr operon of N. gonorrhoeae does not possess abgA-or abgB-related genes (www.genome.ou.edu). Thus, our data suggest that MtrF and AbgT may function differently even though these two membrane proteins belong to the same family.
Given that PABA is an important precursor for folic acid synthesis, we thought that N. gonorrhoeae MtrF might enable uptake of PABA. It should be noted that PABA is capable of diffusing into bacterial cells through the membrane, participating as an intermediate in de novo synthesis of the essential vitamin folic acid. Nonetheless, we compared the radioactive PABA content in cells transformed with either pET15bUmtrF or the empty vector pET15b. Surprisingly, E. coli cells producing N. gonorrhoeae MtrF showed a significant decrease in the level of [ 3 H]-PABA, in contrast to cells transformed with the empty pET15b vector ( Figure 3A ). Instead of an importer, the data strongly suggested to us that MtrF may act as an exporter, capable of expelling the intracellular PABA metabolite from the cell.
In order to determine whether the conserved MtrF residues, D193, S417, W420, P438, R446, D449, and P457, lining the inner wall of the tunnel formed by each protomer are important for the function of the transporter, we mutated each residue to alanine, individually (Table S2) . We expressed these mutant transporters in BL21(DE3)DabgTDpabA. Western analysis suggested that the expression levels of these mutant transporters are comparable with that of wild-type MtrF ( Figure S5 ). In addition, western analysis on the crude cell lysates indicates that the level of expression of the wild-type MtrF transporter was $200 copies per cell ( Figure S6 ). In comparison with the expression level of the AcrB pump, which is $500 copies per cell (Tikhonova and Zgurskaya, 2004) , the expression level of our MtrF proteins should be low enough for physiological measurement. We then measured the accumulation of [ On the contrary, the levels of [ 3 H]-PABA accumulation in cells expressing the mutants W420A and D449A were nearly the same as those transformed with the empty vector, indicating that these mutant transporters are not functional and cannot export PABA from cells. The data suggest that MtrF acts as an efflux pump, and these amino acids are important for its function.
Expression of the MtrF Transporter Decreases Intracellular Folic Acid Concentration
We hypothesized that N. gonorrhoeae MtrF is capable of catalyzing the efflux of the folate metabolite PABA. If this is the case, then cells expressing MtrF should show a lower level of intracellular folic acid concentration. Therefore, we measured the intracellular folic acid content of these cells microbiologically using Lactobacillus casei (Wilson and Horne, 1982) . Cells were grown in liquid minimal medium supplemented with 30 nM PABA. These cells were harvested when the optical density (OD 600 nm ) reached 0.5. Cells were disrupted with a French pressure cell. The crude cell lysates were then assayed microbiologically using L. casei to obtain their folic acid concentrations. Consistent with the results from PABA accumulation, the folic acid concentration in cells producing MtrF were markedly reduced in comparison with cells transformed with the empty vector ( Figure 4 ). These data further support our hypothesis that MtrF acts as an efflux pump and participates in exporting PABA from the cell.
We next investigated how residues D193, S417, W420, P438, R446, D449, and P457 affect the intracellular folic acid concentration. When transformed with plasmids expressing the mutant transporter W420A, folic acid production was restored in these cells and the level of intracellular folic acid concentration was similar to that of the double-knockout strain transformed with the empty vector (Figure 4 ). In addition, cells carrying the mutants, D193A, S417A, P438A, D449A, and P457A, indicated a significant increase in the level of folic acid concentration when compared with cells expressing wild-type MtrF (Figure 4) . Again, the data indicate that these residues are important for the function of the MtrF efflux pump. However, for cells expressing R446A, the intracellular folic acid content was similar to that of cells carrying the wild-type MtrF transporter.
MtrF Is an Antibiotic Efflux Pump
As PABA is an important metabolite for producing the essential folic acid in bacteria, we questioned why the function of MtrF appears to be decreasing the intracellular PABA concentration. We postulated that the answer may lie in the ability of MtrF to protect bacterial cells by extruding antimetabolites that are structurally similar to PABA, specifically sulfonamides. Sulfonamides are antimicrobial agents, sometimes referred to as antimetabolites or growth factor analogs, which are designed to specifically inhibit the essential metabolic pathway for folic acid synthesis in bacterial pathogens. At the chemical level, sulfonamides are structurally similar to the metabolite PABA, making them ideal competitive inhibitors. Sulfonamides were used in the late 1930s and early 1940s to treat gonorrhea, but the rapid emergence of strains resistant to this class of drug resulted in its removal once penicillin became available (Unemo and Shafer, 2014) ; resistant strains were later found to contain mutations in folP that encodes the target for sulfonamides. We therefore suspect that MtrF may be a drug efflux pump, which is capable of recognizing and extruding sulfonamide antimetabolites. In fact, we found that the minimum inhibitory concentration (MIC) of sulfanilamide for the N. gonorrhoeae strain WV16 (an mtrF knockout strain) differed from that of the N. gonorrhoeae parental strain FA140 by 2-fold (MIC of 250 versus 500 mg/ml, respectively).
To determine whether MtrF behaves like a sulfonamide efflux pump, we used E. coli as a surrogate host. We transformed BL21(DE3)DabgTDpabA with pET15bUmtrF or pET15b and tested for the susceptibility of these transformants to four different sulfonamide antimetabolites, sulfamethazine, sulfadiazine, sulfathiazole, and sulfanilamide (Table S3) . It is important to stress that in many instances expression of drug efflux pumps, including members of the RND (Tseng et al., 1999; Li et al., 1995; Rosenberg et al., 2000) and multidrug and toxic compound extrusion (MATE) superfamilies (Brown et al., 1999; Long et al., 2008; Rouquette-Loughlin et al., 2003) , can have only modest changes (2-fold) in bacterial susceptibility to certain antimicrobials, while more significant changes in susceptibility to other agents can be observed in the same system. We found that the BL21(DE3)DabgTDpabA cells producing MtrF were 32-fold less sensitive to sulfamethazine when compared with BL21(DE3)DabgTDpabA cells containing the empty pET15b vector. In addition, this BL21(DE3)DabgTDpabA/pET15bUmtrF transformant was found to be eight times more resistant to sulfanilamide in comparison to the double-knockout cells transformed with pET15b. We also found that the MICs of BL21(DE3) DabgTDpabA/pET15bUmtrF cells for sulfadiazine and sulfathiazole were both greater than eight times than those of BL21(DE3) DabgTDpabA cells carrying the empty vector pET15b. These data indeed indicate that MtrF functions as a drug efflux pump and reduced bacterial susceptibility to sulfonamides.
The binding affinities of these four sulfonamide drugs, sulfamethazine, sulfadiazine, sulfathiazole, and sulfanilamide, as well as PABA for the MtrF transporter were then determined using isothermal titration calorimetry (ITC). The data indicate that the dissociation constants, K D s, for sulfamethazine, sulfadiazine, sulfathiazole, sulfanilamide, and PABA bindings are 0.33 ± 0.02, 12.74 ± 0.62, 1.52 ± 0.07, 1.14 ± 0.01, and 0.54 ± 0.02 mM, respectively ( Figure S7 ; Table S4 ). These ligand-binding experiments indeed confirm that MtrF is capable of recognizing these ligands.
In order to further test the drug efflux capability of MtrF, we expressed the mutant transporters D193A, S417A, W420A, P438A, R446A, D449A, and P457A in BL21(DE3)DabgTDpabA and evaluated for their ability to confer sulfamethazine, sulfadiazine, sulfathiazole, and sulfanilamide resistance. In most cases, we found that strain BL21(DE3)DabgTDpabA carrying these MtrF mutants are more sensitive to sulfamethazine and sulfanilamide in comparison with cells expressing wild-type MtrF (Table S3) . With the exception of the R446 variant, our data indicate that strain BL21(DE3)DabgTDpabA carrying the MtrF mutants were hypersensitive to sulfadiazine and sulfathiazole in comparison with cells expressing wild-type MtrF (Table S3) . These data indeed agree with the idea that these residues are essential for the function of MtrF.
To confirm these drug-susceptibility testing results, we measured the accumulation of radioactive sulfonamide in BL21(DE3)DabgTDpabA cells carrying pET15bUmtrF or pET15b. For these experiments, we compared the accumulation of [ When transformed with plasmids expressing the mutant transporters, D193A, S417A, W420A, P438A, R446A, D449A, and P457A, the level of intracellular sulfamethazine accumulation were much higher than that of cells expressing wild-type MtrF ( Figure 5 ). Again, these data indicate that residues D193, S417, W420, P438, R446, D449, and P457 are critical for the function of the MtrF efflux pump.
In addition, we determined the binding affinities of sulfamethazine, sulfadiazine, sulfathiazole, sulfanilamide, and PABA for the W420A mutant transporter using ITC. The data depict that the K D s, for sulfamethazine, sulfadiazine, sulfathiazole, sulfanilamide and PABA bindings are 10.78 ± 1.17, 105.82 ± 25.60, 50.76 ± 8.90, 6.80 ± 1.49, and 41.15 ± 11.50 mM, respectively (Table S5 ). These bindings are much weaker than those of wild-type MtrF, suggesting that residue W420 is critical for the function of the protein.
MtrF Behaves as a PMF-Dependent Drug Efflux Pump
It has been suggested that members of the AbgT family use the proton-motive-force (PMF) to transport substrates across the membrane (Prakash et al., 2003) . To elucidate whether N. gonorrhoeae MtrF is a PMF-dependent transporter, we measured the level of intracellular sulfamethazine accumulation in the presence of carbonyl cyanide m-chlorophenylhydrazone (CCCP), a de-coupler of the membrane proton gradient. After the addition of CCCP into the assay solution, the accumulation of [ 3 H]-sulfamethazine increased drastically in the MtrF-expressing cells ( Figure 6A ), suggesting the possibility that MtrF is PMF dependent. We then investigated the accumulation level of radioactive sulfamethazine in strain BL21(DE3)DabgTDpabA/pET15bUmtrF in the presence of NaCl or KCl. The concentrations of these metal ions were either 5 or 100 mM. In all cases, the levels of accumulation of [ 3 H]-sulfamethazine were similar to that in the MtrF-producing strain without the addition of any metal ions (Figures 5  and 6A ), indicating that the function of MtrF is independent of Na + or K + .
The drug accumulation data strongly suggest that MtrF is a PMF-dependent efflux pump. To test this possibility, we next measured the efflux of adding glucose; thereafter, radioactive measurements were performed both in the absence and presence of 5 mM NaCl. As shown in Figure 6B , the addition of Na + essentially has no effect on sulfamethazine efflux in BL21(DE3)DabgTDpabA/pET15-bUmtrF. These data suggest that MtrF is a PMF-dependent efflux pump.
Conclusions
In this paper, we report the crystal structure of the N. gonorrhoeae MtrF transporter, which reveals a dimeric molecule with a fold very distinct from all other families of transporters. Our experimental data strongly suggest that N. gonorrhoeae MtrF is a drug efflux pump, capable of removing sulfonamide antimetabolites and mediating resistance to this class of drugs in bacterial cells. It is likely that many members of the AbgT family of transporters may serve as antimetabolite efflux pumps to protect cells against these noxious agents.
EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification of N. gonorrhoeae MtrF Briefly, the full-length MtrF membrane protein containing a 6xHis tag at the N terminus was overproduced in E. coli BL21(DE3)DacrB cells, which harbor a deletion in the chromosomal acrB gene, possessing pET15bUmtrF. Cells were grown in 12 l of Luria broth (LB) medium with 100 mg/ml ampicillin at 25 C. When the OD 600 nm reached 0.5, the culture was treated with 0.2 mM isopropyl-b-D-thiogalactopyranoside (IPTG) to induce mtrF expression, and cells were harvested within 15 hr. The collected bacteria were resuspended in buffer containing 100 mM sodium phosphate (pH 7.2), 10% glycerol, 1 mM ethylenediaminetetraacetic acid (EDTA) and 1 mM PMSF and then disrupted with a French pressure cell. The membrane fraction was collected and washed twice with buffer containing 20 mM sodium phosphate (pH 7.2), 2 M KCl, 10% glycerol, 1 mM EDTA, and 1 mM PMSF and once with 20 mM HEPES-NaOH buffer (pH 7.5) containing 1 mM PMSF as described previously (Long et al., 2010 ). The membrane protein was then solubilized in 2% (w/v) ndodecyl-b-D-maltoside (DDM). Insoluble material was removed by ultracentrifugation at 100,000 3 g. The extracted protein was purified with a Ni 2+ -affinity column. The purified protein was dialyzed and concentrated to 20 mg/ml in a buffer containing 20 mM Na-HEPES (pH 7.5) and 0.05% DDM. The 6xHis tag at the N terminus was then cleaved by adding 5 U of thrombin (GE Healthcare) per mg of purified MtrF at room temperature for 20 hr. The protein was subsequently passed through a Ni 2+ -affinity column to remove the free 6xHis tag.
A final purification step was performed using a G200 size exclusion column loaded with buffer solution containing 20 mM Na-HEPES (pH 7.5) and 0.05% DDM. The purity of the MtrF protein (> 95%) was judged using 10% SDS-PAGE stained with Coomassie brilliant blue. The purified protein was then concentrated to 20 mg/ml in a buffer containing 20 mM Na-HEPES (pH 7.5) and 0.05% DDM. For 6xHis selenomethionyl-substituted (SeMet)-MtrF protein expression, a 10 ml LB broth overnight culture containing E. coli BL21(DE3)DacrB/pET15-bUmtrF cells was transferred into 120 ml of LB broth containing 100 mg/ml ampicillin and grown at 37 C. When OD 600 nm value reached 1.2, cells were harvested by centrifugation at 6,000 rev/min for 10 min and then washed two times with 20 ml of M9 minimal salts solution. The cells were re-suspended in 120 ml of M9 media and then transferred into a 12 l pre-warmed M9 solution containing 100 mg/ml ampicillin. The cell culture was incubated at 25 C with shaking. When OD 600 nm reached 0.4, 100 mg/l of lysine, phenylalanine, and threonine, 50 mg/l isoleucine, leucine, and valine, and 60 mg/l of L-selenomethionine were added. The culture was induced with 0.2 mM IPTG after 15 min. Cells were then harvested within 15 hr after induction. The procedures for purifying SeMet-MtrF were identical to those of the native protein.
Crystallization of MtrF
Crystals of the MtrF transporter were obtained using vapor diffusion. The MtrF crystals were grown at room temperature with the following procedures. A 2-ml protein solution containing 20 mg/ml MtrF protein in 20 mM Na-HEPES (pH 7.5) and 0.05% (w/v) DDM was mixed with a 2 ml of reservoir solution containing 30% PEG 400, 0.1 M sodium acetate (pH 5.0), 0.1 M magnesium acetate, 3% glycerol, and 1% (w/v) octyl glucose neopentyl glycol (OGNG). The resultant mixture was equilibrated against 500 ml of the reservoir solution. The crystallization conditions for SeMet-MtrF were the same as those for native MtrF. Crystals of both MtrF and SeMet-MtrF grew to a full size in drops within a Data Collection, Structural Determination, and Refinement All diffraction data were collected at 100K at beamline 24ID-C located at the Advanced Photon Source, using a Pilatus 6M detector (Dectris). Diffraction data were integrated using DENZO and scaled using SCALEPACK (Otwinowski and Minor, 1997). Crystals of MtrF belong to space group P6 5 (Table S1 ). Based on the molecular weight of MtrF (56.3 kDa), two molecules per asymmetric unit with a solvent content of 71.9% were expected. Data from a native crystal, two heavy-atom derivatives, namely, Ta 6 Br 12 2+ and W 6 (m-O) 6 (m-Cl) 6 -Cl 6 2À clusters, and a selenomethionyl-substituted (SeMet) crystal were used for phase determination (Table S1 ). Four tantalum (Ta 6 Br 12 2+ ) cluster sites were identified using SHELXD (Schneider and Sheldrick, 2002) as implemented in the HKL2MAP package (Pape and Schneider, 2004) . These heavy-atom sites were refined using the program AutoSol in PHENIX (Adams et al., 2002) . These phases were then used to locate six tungsten cluster sites using the corresponding W 6 (m-O) 6 (m-Cl) 6 Cl 6 2À data set. Multiple isomorphous replacement with anomalous scattering (MIRAS), including data from the tantalum and tungsten complexes, was performed at a resolution of 5.70 Å using AutoSol implemented in PHENIX (Adams et al., 2002) . These phases were then subjected to density modification, NCS averaging, and phase extension to native 3.95-Å resolution using the program RESOLVE (Terwilliger, 2001) . Density-modified phases were good enough to visualize the secondary structural features of the protein molecule.
After tracing the initial model manually using the program Coot (Emsley and Cowtan, 2004) , molecular replacement with single wavelength anomalous diffraction (MR-SAD) was performed, utilizing the SeMet data, using the program Phaser (McCoy et al., 2007) . The full-length MtrF protein contains 30 methionines (excluding the first N-terminal methionine residue), all of these corresponding 30 selenium sites were found in the difference Fourier map. The electron density map was further improved by multi-crystal averaging, including the two different crystal forms (both SeMet and wild-type) of the MtrF dimer, using PHENIX (Adams et al., 2002) .
The model was then rebuilt and refined against the native data at 3.95 Å -resolution using PHENIX (Adams et al., 2002) , leaving 5% of reflections in Free-R set. Feature-enhanced maps calculated using PHENIX and B-factor sharpening maps created using CCP4 were employed to ascertain loop-regions and side chains in the structure. Iterations of refinement using PHENIX (Adams et al., 2002) and CNS (Brü nger et al., 1998) and model building in Coot (Emsley and Cowtan, 2004) lead to the current structural model of the MtrF transporter (Table S1 ). The sulfur atom positions of all 30 methionines coincide with their corresponding Se peaks in the anomalous map.
Gel Filtration
A protein liquid chromatography Superdex 200 16/60 column (GE Healthcare) with a mobile phase containing 20 mM Na-HEPES (pH 7.5) and 0.05% (w/v) DDM was used in the gel filtration experiments. Blue dextran (Sigma-Aldrich) was used to determine the column void volume. As there are no commercially available membrane protein markers, we used the well-characterized N. gonorrhoeae NorM multidrug efflux pump (Lu et al., 2013; Long et al., 2008) (which exists as a monomer in solution with the monomeric molecular weight equals 50.6 kDa) and E. coli CusC outer membrane channel (Kulathila et al., 2011; Lei et al., 2014a) (which exists as a trimer in solution with the trimeric molecular weight equals 147.7 kDa) as standards. The experiments were repeated for three times. Gel filtration suggested an average molecular weight of 112.1 ± 4.1 kDa for the MtrF transporter ( Figure S3 ). This value is in good agreement with the theoretical value of 112.5 kDa for two MtrF protomers.
Construction of the Double-Knockout Strain
The double-knockout E. coli strain BL21(DE3)DabgTDpabA was produced from the BL21(DE3) strain using an RED disruption system as described by Datsenko and Wanner (2000) . The DabgT::kan cassette, which was used to replace the chromosomal abgT gene, was produced by PCR and then introduced into pKD46/BL21(DE3) by electroporation. The knockout BL21(DE3)DabgT::kan strain was selected on LB plate containing 30 mg/ml kanamycin and verified by PCR. The kanamycin-resistant gene was then released to generate the BL21(DE3)DabgT knockout strain. The deletion of pabA from BL21(DE3)DabgT was done using similar procedures as described above to generate the final BL21(DE3)DabgTDpabA doubleknockout strain.
Site-Directed Mutagenesis
We performed site-directed mutagenesis on residues D193, S417, W420, P438, R446, D449, and P457 to generate single point mutants D193A, S417A, W420A, P438A, R446A, D449A, and P457A. The primers used for these mutations are listed in Table S2 . All oligonucleotides were purchased from Integrated DNA Technologies in a salt-free grade.
Accumulation Assays of p-Aminobenzoic Acid In brief, E. coli BL21(DE3)DabgTDpabA carrying pET15bUmtrF or pET15b were grown in LB broth with 100 mg/ml ampicillin at 37 C. When OD 600 nm reached 0.5, the culture was treated with 0.2 mM IPTG to induce mtrF expression, and cells were harvested within 2 hr. Cells were washed twice with buffer containing 50 mM potassium phosphate (pH 7.5), twice with buffer containing 100 mM Tris-HCl (pH 7.5), and then suspended in the same buffer to OD 600 nm of 15.
[ 3 H]-PABA (Moravek Biochemicals) was then added to a final concentration of 0.3 mM. Samples of 100 ml were taken at intervals, applied directly to prewetted glass-fiber filters, and washed twice with 5-ml aliquots of the same buffer; 0.5-mm glass-fiber filters (MFS) were used with a filter apparatus. Filters were then incubated for 30 min in scintillation fluid (ScintiVerse BD) and counted with a Packard Tri-Carb 1600TR liquid scintillation counter (PerkinElmer). For [ 3 H]-PABA accumulations in cells expressing the MtrF mutants, the procedures for sample preparation were the same as above.
Assays of Folic Acid
The concentration of folic acid in the double-knockout BL21(DE3)DabgTD pabA strain transformed with pET15bUmtrF or pET15b was measured using Lactobacillus casei based on the microbiological procedure of Wilson and Horne (1982) . The concentrations of folic acid in BL21(DE3)DabgTDpabA expressing the mutant transporters were measured using the same procedures.
Drug-Susceptibility Assays
The susceptibilities to various drugs of E. coli BL21(DE3)DabgTDpabA harboring pET15bUmtrF expressing the wild-type or mutant transporters, or the pET15b empty vector were tested on agar plates. Cells were grown in Luria broth (LB) medium with 100 mg/ml ampicillin at 37 C. When OD 600 nm reached 0.5, the cultures were induced with 0.2 mM IPTG and harvested in 2 hr after induction. The MICs to sulfamethazine, sulfadiazine, sulfathiazole, and sulfanilamide of E. coli BL21(DE3)DabgTDpabA (incoculum, 500 cells/ml) harboring these vectors were then determined using LB agar containing 50 mg/ml ampicillin, 0.1 mM IPTG, and different concentrations of these drugs.
For the MIC studies with N. gonorrhoeae cells, we used strains FA140 and WV16 (as FA140 but mtrF::kan) described by Veal and Shafer (2003) . These strains were grown on GCB agar plates. The susceptibilities to sulfanilamide were performed using the agar dilution assay described by .
Isothermal Titration Calorimetry
We used ITC to examine the binding of a variety of ligands to the purified MtrF transporter. Measurements were performed on a VP-Microcalorimeter (MicroCal) at 25 C. Before titration, the protein was thoroughly dialyzed against buffer containing 20 mM Tris-HCl (pH 7.5) and 0.03% DDM. The protein concentration was determined using the Bradford assay. The protein sample was then adjusted to a final monomeric concentration of 40 mM. Ligand solution consisting of 1.0 mM sulfamethazine, sulfadiazine, sulfathiazole, sulfanilamide, or PABA in 20 mM Tris-HCl (pH 7.5) and 0.03% DDM was prepared as the titrant. The protein and ligand samples were degassed before they were loaded into the cell and syringe. Binding experiments were carried out with the protein solution (1.5 ml) in the cell and the ligand as the injectant. Ten-microliter injections of the ligand solution were used for data collection. Injections occurred at intervals of 300 s, and the duration time of each injection was 20 s. Heat transfer (mcal/s) was measured as a function of elapsed time (s). The mean enthalpies measured from injection of the ligand in the buffer were subtracted from raw titration data before data analysis with ORIGIN software (MicroCal). Titration curves were fitted by a nonlinear leastsquares method to a function for the binding of a ligand to a macromolecule. Nonlinear regression fitting to the binding isotherm provided us the equilibrium binding constant (K A = 1/K D ). Calorimetry trials were also carried out in the absence of MtrF in the same experimental conditions. No change in heat was observed in the injections throughout the experiment. NaCl or KCl (5 or 100 mM) for 15 min and then applied directly to prewetted glass-fiber filters and washed immediately twice with 5-ml aliquots of buffer containing 100 mM Tris-HCl (pH 7.5) and 5 or 100 mM salt (NaCl or KCl).
Efflux Assays of Sulfamethazine E. coli BL21(DE3)DabgTDpabA carrying pET15bUmtrF or pET15b were grown in LB broth with 100 mg/ml ampicillin at 37 C. When OD 600 nm reached 0.5, the culture was induced with 0.2 mM IPTG, and cells were harvested within 2 hr. Cells were washed twice with buffer containing 50 mM potassium phosphate (pH 7.5), twice with buffer containing 100 mM Tris-HCl (pH 7.5) and then suspended in the same buffer to OD 600 nm of 15. CCCP was added to the cell suspension at a final concentration of 100 mM. Cells were then incubated for 10 min, pelleted, washed twice, and resuspended in the same buffer to OD 600 nm of 10.
[ 3 H]-sulfamethazine was then added to a final concentration of 37 nM. Cells were incubated for 15 min, and a final concentration of 0.2% glucose was then added to the cell suspension. When needed, a final concentration of 5 mM NaCl was also added at the same time. At various time points, samples of 100 ml were applied directly to prewetted glass-fiber filters, and washed twice with 5-ml aliquots of buffer containing 100 mM Tris-HCl (pH 7.5). Filters were then incubated for 30 min in scintillation fluid (ScintiVerse BD) and counted with a Packard Tri-Carb 1600TR liquid scintillation counter (PerkinElmer).
ACCESSION NUMBERS
Atomic coordinates and structure factors for the structure of MtrF have been deposited at the RCSB Protein Data Bank and are available under accession number 4R1I. 
